Learning the language of viral evolution and escape
暂无分享,去创建一个
Brian Hie | Ellen D. Zhong | Bonnie Berger | Bryan Bryson | Ellen Zhong | Bryan D. Bryson | B. Berger | B. Hie | B. Bryson
[1] Zellig S. Harris,et al. Distributional Structure , 1954 .
[2] Zellig S. Harris,et al. Distributional Structure , 1954 .
[3] Michael S. Kay,et al. Protein Design of an HIV-1 Entry Inhibitor , 2001, Science.
[4] P S Kim,et al. Mechanisms of viral membrane fusion and its inhibition. , 2001, Annual review of biochemistry.
[5] P S Kim,et al. Mechanisms of viral membrane fusion and its inhibition. , 2001, Annual review of biochemistry.
[6] Peter Auer,et al. Using Confidence Bounds for Exploitation-Exploration Trade-offs , 2003, J. Mach. Learn. Res..
[7] Peter Auer,et al. Using Confidence Bounds for Exploitation-Exploration Trade-offs , 2003, J. Mach. Learn. Res..
[8] Martin A. Nowak,et al. Antibody neutralization and escape by HIV-1 , 2003, Nature.
[9] Martin A. Nowak,et al. Antibody neutralization and escape by HIV-1 , 2003, Nature.
[10] D. Richman,et al. Rapid evolution of the neutralizing antibody response to HIV type 1 infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] D. Richman,et al. Rapid evolution of the neutralizing antibody response to HIV type 1 infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. J. Stevens,et al. The Structure and Receptor Binding Properties of the 1918 Influenza Hemagglutinin , 2004, Science.
[13] D. J. Stevens,et al. The Structure and Receptor Binding Properties of the 1918 Influenza Hemagglutinin , 2004, Science.
[14] J. Overbaugh,et al. Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity , 2006, Journal of Virology.
[15] J. Overbaugh,et al. Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity , 2006, Journal of Virology.
[16] B. Eaton,et al. Bats, Civets and the Emergence of SARS , 2007, Current topics in microbiology and immunology.
[17] B. Eaton,et al. Bats, Civets and the Emergence of SARS , 2007, Current topics in microbiology and immunology.
[18] Sean R. Eddy,et al. A Probabilistic Model of Local Sequence Alignment That Simplifies Statistical Significance Estimation , 2008, PLoS Comput. Biol..
[19] Sean R. Eddy,et al. A Probabilistic Model of Local Sequence Alignment That Simplifies Statistical Significance Estimation , 2008, PLoS Comput. Biol..
[20] Jean-Loup Guillaume,et al. Fast unfolding of communities in large networks , 2008, 0803.0476.
[21] Gira Bhabha,et al. Antibody Recognition of a Highly Conserved Influenza Virus Epitope , 2009, Science.
[22] Gira Bhabha,et al. Antibody Recognition of a Highly Conserved Influenza Virus Epitope , 2009, Science.
[23] Chih-Jen Wei,et al. Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design , 2010, Science Translational Medicine.
[24] Chih-Jen Wei,et al. Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design , 2010, Science Translational Medicine.
[25] R. Sanjuán,et al. Viral Mutation Rates , 2010, Journal of Virology.
[26] R. Sanjuán,et al. Viral Mutation Rates , 2010, Journal of Virology.
[27] James E. Crowe,et al. Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus , 2010, Science.
[28] Tomer Hertz,et al. Putative amino acid determinants of the emergence of the 2009 influenza A (H1N1) virus in the human population , 2011, Proceedings of the National Academy of Sciences.
[29] Tomer Hertz,et al. Putative amino acid determinants of the emergence of the 2009 influenza A (H1N1) virus in the human population , 2011, Proceedings of the National Academy of Sciences.
[30] R. Swanstrom,et al. The HIV-1 Env Protein: A Coat of Many Colors , 2012, Current HIV/AIDS Reports.
[31] R. Swanstrom,et al. The HIV-1 Env Protein: A Coat of Many Colors , 2012, Current HIV/AIDS Reports.
[32] K. Katoh,et al. MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.
[33] K. Katoh,et al. MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.
[34] Jeffrey Dean,et al. Distributed Representations of Words and Phrases and their Compositionality , 2013, NIPS.
[35] Jeffrey Dean,et al. Distributed Representations of Words and Phrases and their Compositionality , 2013, NIPS.
[36] Michael J Sailor,et al. Mesoporous silicon sponge as an anti-pulverization structure for high-performance lithium-ion battery anodes , 2014, Nature Communications.
[37] Y. Guan,et al. MERS Coronaviruses in Dromedary Camels, Egypt , 2014, Emerging infectious diseases.
[38] Y. Guan,et al. MERS Coronaviruses in Dromedary Camels, Egypt , 2014, Emerging infectious diseases.
[39] Y. Iba,et al. Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus , 2014, Nature Communications.
[40] Y. Iba,et al. Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus , 2014, Nature Communications.
[41] Quoc V. Le,et al. Semi-supervised Sequence Learning , 2015, NIPS.
[42] Quoc V. Le,et al. Semi-supervised Sequence Learning , 2015, NIPS.
[43] D. Cummings,et al. Estimating the Life Course of Influenza A(H3N2) Antibody Responses from Cross-Sectional Data , 2015, PLoS biology.
[44] D. Cummings,et al. Estimating the Life Course of Influenza A(H3N2) Antibody Responses from Cross-Sectional Data , 2015, PLoS biology.
[45] Debora S. Marks,et al. Quantification of the effect of mutations using a global probability model of natural sequence variation , 2015, 1510.04612.
[46] Michael B. Doud,et al. Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin , 2016, Viruses.
[47] Michael B. Doud,et al. Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin , 2016, Viruses.
[48] Young Do Kwon,et al. Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G , 2016, Cell.
[49] P. Collins,et al. Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes , 2016, Cell.
[50] Thomas A. Hopf,et al. Mutation effects predicted from sequence co-variation , 2017, Nature Biotechnology.
[51] Fabian J Theis,et al. SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.
[52] R. Webster,et al. Influenza Virus: Dealing with a Drifting and Shifting Pathogen. , 2018, Viral immunology.
[53] R. Webster,et al. Influenza Virus: Dealing with a Drifting and Shifting Pathogen. , 2018, Viral immunology.
[54] Galit Alter,et al. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) , 2018, The Lancet.
[55] Michael B. Doud,et al. How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin , 2018, Nature Communications.
[56] Michael B. Doud,et al. How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin , 2018, Nature Communications.
[57] Mapping mutational effects along the evolutionary landscape of HIV envelope , 2018, eLife.
[58] Mapping mutational effects along the evolutionary landscape of HIV envelope , 2018, eLife.
[59] Leland McInnes,et al. UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction , 2018, ArXiv.
[60] Leland McInnes,et al. UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction , 2018, ArXiv.
[61] Luke S. Zettlemoyer,et al. Deep Contextualized Word Representations , 2018, NAACL.
[62] Luke S. Zettlemoyer,et al. Deep Contextualized Word Representations , 2018, NAACL.
[63] Matthew R. McKay,et al. Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies , 2018, Proceedings of the National Academy of Sciences.
[64] Dariusz M Plewczynski,et al. Three-dimensional Epigenome Statistical Model: Genome-wide Chromatin Looping Prediction , 2018, Scientific Reports.
[65] P. Wilson,et al. The influenza virus hemagglutinin head evolves faster than the stalk domain , 2018, Scientific Reports.
[66] Andrew Rambaut,et al. HIV Sequence Compendium 2018 , 2018 .
[67] F. Krammer. The human antibody response to influenza A virus infection and vaccination , 2019, Nature Reviews Immunology.
[68] F. Krammer. The human antibody response to influenza A virus infection and vaccination , 2019, Nature Reviews Immunology.
[69] Bonnie Berger,et al. Geometric Sketching Compactly Summarizes the Single-Cell Transcriptomic Landscape. , 2019, Cell systems.
[70] Bonnie Berger,et al. Learning protein sequence embeddings using information from structure , 2019, ICLR.
[71] Niema Moshiri,et al. TreeCluster: clustering biological sequences using phylogenetic trees , 2019 .
[72] George M. Church,et al. Unified rational protein engineering with sequence-based deep representation learning , 2019, Nature Methods.
[73] George M. Church,et al. Unified rational protein engineering with sequence-based deep representation learning , 2019, Nature Methods.
[74] Niema Moshiri,et al. TreeCluster: Clustering biological sequences using phylogenetic trees , 2019, bioRxiv.
[75] Ilya Sutskever,et al. Language Models are Unsupervised Multitask Learners , 2019 .
[76] J. Bloom,et al. Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin , 2019, bioRxiv.
[77] Ming-Wei Chang,et al. BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding , 2019, NAACL.
[78] Ming-Wei Chang,et al. BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding , 2019, NAACL.
[79] J. Bloom,et al. Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin , 2019, bioRxiv.
[80] J. Bloom,et al. Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin , 2019, bioRxiv.
[81] Robert P. Sheridan,et al. The EVcouplings Python framework for coevolutionary sequence analysis , 2018, bioRxiv.
[82] Robert P. Sheridan,et al. The EVcouplings Python framework for coevolutionary sequence analysis , 2018, bioRxiv.
[83] John Canny,et al. Evaluating Protein Transfer Learning with TAPE , 2019, bioRxiv.
[84] John Canny,et al. Evaluating Protein Transfer Learning with TAPE , 2019, bioRxiv.
[85] J. Bloom,et al. An Antigenic Atlas of HIV‐1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes , 2019, Immunity.
[86] J. Bloom,et al. An Antigenic Atlas of HIV‐1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes , 2019, Immunity.
[87] I. Wilson,et al. Major antigenic site B of human influenza H3N2 viruses has an evolving local fitness landscape , 2020, Nature Communications.
[88] Jesse D. Bloom,et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding , 2020, bioRxiv.
[89] Jesse D. Bloom,et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding , 2020, bioRxiv.
[90] P. Carmeliet,et al. PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase , 2020, Nature Communications.
[91] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[92] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[93] D. Baker,et al. Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines , 2020, bioRxiv.
[94] D. Baker,et al. Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines , 2020, bioRxiv.
[95] G. Atwal,et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies , 2020, Science.
[96] G. Atwal,et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies , 2020, Science.
[97] E. Holmes,et al. The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.
[98] E. Holmes,et al. The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.
[99] S. Khurana,et al. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits , 2020, Science Translational Medicine.
[100] S. Khurana,et al. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits , 2020, Science Translational Medicine.